- Colposcopy and Programme Management: Guidelines for the NHS Cervical Screening Programme. Second edition. NHSCSP Publication No.20, May 2010. At: www.cancerscreening.nhs.uk/cervical/publications/nhscsp20.html
- Smith JS, Gilbert PA, Melendy A, et al. Age-specific prevalence of human papillomavirus infection in males: a global review. Journal of Adolescent Health. 2011; 48: 540–52.
- Banura C, Mirembe FM, Katahoire AR, et al. Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: a systematic review. Infectious Agents Cancer. 2011; 6 (1): 11.
- Tachezy R, Smahelova J, Salakova M, et al. Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One. 2011; 6(7): e21913.
- Dietz CA, Nyberg CR. Genital, oral, and anal human papillomavirus infection in men who have sex with men. Journal of the American Osteopath Association 2011;111(3 Suppl.2):S19–S25.
- Guiliano AR, Palefsky JM, Goldstone S, at al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New England Journal of Medicine 2011; 364 (5): 401–11.
- Moreira ED, Palefsky JM, Giuliano AR, et al. Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-likeparticle vaccine in older adolescents and young adults. Human Vaccines. 2011; 7(7).
- Rehmeyer CJ. Male circumcision and human papillomavirus studies reviewed by infection stage and virus type. Journal of American Osteopath Association 2011;111(3 Suppl.2):S11–S18.
- Smith MA, Lew JB, Walker RJ, et al. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine 2011;Mar 17.
Reproductive Health Matters
An international journal on sexual and reproductive health and rights
Volume 19, 2011 - Issue 38: Repoliticisation of SRH services